|
|
|
| Effects of Dexmetomidine hydrochloride on hemodynamics and stress response in patients with pseudomyxoma peritonei |
| LU Liangyuan XUE Yanyan ZHANG Guyue YANG Zhanmin |
| Department Anesthesiology, Beijing Aerospace Center Hospital, Beijing 100049, China |
|
|
|
Abstract Objactive To study the effects of Dexmedetomidine hydrochloride on hemodynamics and stress response in patients with pseudomyxoma peritonei. Methods Forty-six patients with pseudomyxoma peritonei in Beijing Aerospace Center Hospital from June 2015 to October 2017 were selected and devided into Dexmedetomidine group (24 cases) and control group (22 cases) by randomly number table method. After entered the operating room, patients of two groups were given the 0.5 μg/kg·h Dexmedetomidine or the same dose of normal saline, after 10 minutes, anesthesia induction. The blood samples were extracted and tested at the time before anesthesia induction (T1), 3 minutes after endotracheal intubation (T2), before intraperitoneal hyperthermic perfusion chemotherapy (T3), after thermal perfusion (T4), end of the surgery (T5). The heart rate (HR), MAP, cardiac output (CO), stroke volume variation (SVV), Tnose, blood glucose (Glu), plasma norepinephrine (NE) and epinephrine (E) were recorded. Results Hormone levels: the plasma E and NE levels in Dexmedetomidine group were lower than control group at T2-T5 (P ＜ 0.05). Hemodynamics: In Dexmedetomidine group of T3, T4 and T5, the change of CO and SVV was better than that of normal saline control group (P ＜ 0.05). The average MAP in Dexmedetomidine group was higher than the control group, the dosage of Propofol was lower than that of control group, the differences were statistically significant (P ＜ 0.05). There was no statistical significance between the two groups in preoperative, postoperative PCI index, CVP, Glu, time of operation, blood volume, urine volume and liquid amount (P ＞ 0.05). Conclusion Dexmedetomidine hydrochloride can reduce the reaction of injury in patients with pseudomyxoma peritonei, which is beneficial to reduce the hemodynamic fluctuation during the operation.
|
|
|
|
|
|
[1] 吴孟超，吴在德.黄家驷外科学[M].北京：人民卫生出版社，2008：1359.
[2] 李雁，周云峰，梁寒等.细胞减灭术加腹腔热灌注化疗治疗腹膜表面肿瘤的专家共识[J].中国肿瘤临床，2015，42（4）：198-206.
[3] Shiralkar SP，Kerr P，Scott J，et al. Anaesthetic management of patients undergoing cytoreductive surgery with hyperth?鄄ermic intraperitoneal chemotherapy for pseudomyxoma peri?鄄tonei：a retrospective audit[J].Anaesth Intensive Care，2017，45（4）：490-498.
[4] Ashraf-Kashani N，Bell J. Haemodynamic changes during hyperthermic intra-thoracic chemotherapy for pseudomy?鄄xoma peritonei [J]. Int J Hyperthermia，2017，33（6）：675-678.
[5] 吴新民，许幸，王俊科，等.静脉注射右美托咪啶辅助全身麻醉的有效性和安全性[J].中华麻醉学杂志，2007，27（9）：773-776.
[6] 李民，张利萍，吴新民.右美托咪啶在临床麻醉中应用的研究进展[J].中国临床药理学杂志，2007，23（6）：466-470.
[7] Wang Z，Chen Q，Guo H，et al. Effects of?dexmedetomidine on H-FABP， CK-MB， cTnI levels， neurological function and near-term prognosis in patients undergoing heart valve replacement [J]. Exp Ther Med，2017，14（6）：5851-5856.
[8] Khare A，Sharma SP，Deganwa ML，et al. Effects of Dexmedetomidine on Intraoperative Hemodynamics and Propofol Requirement in Patients Undergoing Laparoscopic Cholecystectomy [J]. Anesth Essays Res，2017，11（4）：1040-1045.
[9] Kunisawa T，Nagata O，Nagashima M，et al. Dexmedetomidine suppresses the decrease in blood pressure during anesthetic induction and blunts the cardiovascular response to tracheal intubation [J]. J Clin Anesth，2009，21（3）：194-199
[10] 赵艳军，冯泽国，米卫东，等.右美托咪定复合七氟烷在腹腔镜前列腺癌根治手术中的应用[J].北京医学，2013， 35（8）：614-617.
[11] Kotake Y，Yamada T，Nagata H，et al. Transient hemodynamic change and accuracy of arterial blood pressure-based cardiac output [J]. Anesth Analg，2011，113（2）：272-274.
[12] Jalonen J，Hynynen M，Kuitunen A，et al. Dexmedetomidine as an anesthetic adjunct in coronary artery bypass grafting [J]. Anesthesiology，1997，86（2）：331-345.
[13] Lee SH，Kim N，Lee CY，et al. Effects of dexmedetomidine on oxygenation and lung mechanics in patients with moderate chronic obstructive pulmonary disease undergoing lung cancer surgery：A randomised double-blinded trial [J]. Eur J Anaesthesiol，2016，33（4）：275-282.
[14] Türktan M，Güne Y，Yalιnιz H，et al. Comparison of the cardioprotective effects of dexmedetomidineand remifentanil in cardiac surgery [J]. Turk J Med Sci，2017，47（5）：1403-1409.
[15] Soliman R，Hussien M，Comparison of the renoprotective effect of dexmedetomidine and dopamine in high-risk renal patients undergoing cardiac surgery：A double-blind randomized study [J]. Ann Card Anaesth，2017，20（4）：408-415.
[16] Gautam NK，Turiy Y，Srinivasan C. Preincision Initiation of Dexmedetomidine Maximally Reduces the Risk of Junctional Ectopic Tachycardia in Children Undergoing Ventricular Septal Defect Repairs [J]. J Cardiothorac Vasc Anesth，2017，31（6）：1960-1965.
[17] Davy A，Fessler J，Fischler M，et al.Dexmedetomidine and general anesthesia： a narrative literature review of its major indications for use in adults undergoing non-cardiac surgery [J]. Minerva Anestesiol，2017，83（12）：1294-1308.
[18] 胡宪文，张野，孔令锁，等.不同剂量右美托咪啶抑制气管插管诱发患者心血管反应效应的比较[J].中华麻醉学杂志，2010，30（11）：1304-1306.
[19] 杨占民，郑翔丽，梁汉生，等.术中腹腔内持续热灌注化疗术对腹腔假黏液瘤患者围术期呼吸力学、血流动力学及生化代谢的影响[J].北京医学，2014，8：639-642.
[20] Yamasaki T，Komasawa N，Matsunami S，et al. Anesthetic Management of Peritonectomy and Extended Operation for Peritoneal Pseudomyxoma Combined with Massive Ascites [J]. Masui，2016，65（6）：605-609.
[21] Sargant N，Roy A，Simpson S，et al. A protocol for management of blood loss in surgical treatment of peritoneal malignancy by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy [J]. Transfus Med，2016，26（2）：118-122.
[22] Mukhtar AM，Obayah EM，Hassona AM. The use of dexmedetomidine in pediatric cardiac surgery [J]. Anesth Analg，2006，103（1）：52-56.
[23] Sethi P，Gupta N. Effect of dexmedetomidine on blood glucose during surgery [J]. J Anaesthesiol Clin Pharmacol，2017，33（3）：411-412. |
|
|
|
